TransMedics Group Inc.

69.43
-6.89 (-9.03%)
At close: Mar 03, 2025, 3:59 PM
68.77
-0.95%
Pre-market: Mar 04, 2025, 05:52 AM EST

TransMedics Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income n/a -25.03M -36.23M -44.22M -28.75M -33.55M -23.76M -20.82M -24.07M
Depreciation & Amortization n/a 8.18M 3.48M 1.82M 1.58M 1.22M 769K 630K 426K
Stock-Based Compensation n/a 19.79M 10.32M 6.88M 2.41M 854K 144K 70K 45K
Other Working Capital n/a 10.6M 6.21M 1.97M 2.17M 2.22M 721K 26K 411K
Other Non-Cash Items 48.8M 30.04M 3.37M 1.37M 511K 475K 177K 93K 65K
Deferred Income Tax n/a -1.66M n/a 2.28M -431K 336K 1.01M -316K 292K
Change in Working Capital n/a -44.35M -26.76M 3M -5.59M -1.63M -4.33M -2.75M -872K
Operating Cash Flow 48.8M -13.03M -45.82M -28.86M -30.27M -32.29M -25.98M -23.1M -24.11M
Capital Expenditures n/a -179.06M -11.91M -3.52M -455K -165K -418K -263K -1.48M
Acquisitions 441K -14.89M 107K -32.79M 41.14M 60.34M n/a n/a n/a
Purchase of Investments n/a n/a -10.5M -72.02M -121.79M -82.37M n/a -19.19M -46.53M
Sales Maturities Of Investments n/a n/a 76.92M 104.81M 80.65M 22.04M 12.72M 44.31M 8.34M
Other Investing Acitivies -129.74M -27.21M -107K 32.79M -41.14M -60.34M 12.72M 25.12M -38.19M
Investing Cash Flow -129.3M -193.95M 54.51M 29.27M -41.6M -60.5M 12.31M 24.86M -39.67M
Debt Repayment n/a 445.38M 22.46M n/a n/a n/a 24.36M n/a n/a
Common Stock Repurchased n/a 955K n/a 419K n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 22.87M -52.07M 5.61M 1.39M 584K -4.64M -2.3M 3K 63.54M
Financial Cash Flow 22.87M 400.42M 167.93M 1.39M 75.55M 92.72M 22.06M 3K 63.54M
Net Cash Flow -58.16M 193.63M 175.6M 999K 4.49M -149K 8.3M 2.1M -243K
Free Cash Flow 48.8M -192.09M -57.72M -32.38M -30.72M -32.45M -26.4M -23.36M -25.59M